Test Price
2,800 AED✅ Home Collection Available
PPP2R2B Gene Spinocerebellar Atrophy Type 12 (SCA12) Autosomal Dominant Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين PPP2R2B للرنح النخاعي المخيخي النوع 12 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary ملخص تنفيذي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing. ضمان دقة تشخيصية بنسبة 99.9% عبر معالجة معتمدة من ISO.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
The PPP2R2B gene analysis detects pathogenic variants causing Spinocerebellar Ataxia Type 12 (SCA12), an autosomal dominant neurodegenerative disorder. This NGS-based test provides definitive molecular diagnosis for at-risk individuals and guides clinical management, family planning, and eligibility for targeted therapies.
| Feature | Our Test (Premium) | Closest Alternative |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity (NGS with orthogonal confirmation) | ~97% with Sanger-only fragments |
| Methodology | Next-Generation Sequencing (Illumina® platform), full gene coverage | Single-gene Sanger sequencing (limited to hotspot) |
| Turnaround Time | 3–4 weeks with expedited reporting | 5–7 weeks in standard labs |
Physician Insight & Safety Protocol
“A positive PPP2R2B genetic result must be correlated with comprehensive neurological assessment and brain imaging before concluding a diagnosis of SCA12. I strongly advise all patients to involve a clinical geneticist for accurate penetrance estimation and to never interpret raw data without expert counsel.”
⚠️ Medication Warning
Do not discontinue any prescribed medication (e.g., antiepileptics, baclofen, levodopa) without explicit consultation with your treating physician. Abrupt withdrawal may precipitate severe neurological deterioration.
Exclusion Criteria & ER Red Flags
- Exclusion: Inability to provide informed consent; patient under active chemotherapy within 2 weeks (may affect DNA quality).
- Red Flags Requiring Emergency Visit: Acute onset of severe ataxia with loss of ambulation, dysphagia, or respiratory distress—proceed to ER immediately regardless of pending genetic results.
- Pediatric Note: For minors, genetic testing must comply with UAE CDS Law 2026; mandatory pre-test counseling and legal guardian consent.
Patient FAQ & Clinical Guidance
1. What exactly does this test detect, and who should consider it?
This NGS test identifies pathogenic variants in the PPP2R2B gene that cause Spinocerebellar Ataxia Type 12, an autosomal dominant disorder typically presenting with progressive cerebellar ataxia and tremor in adulthood. Individuals with a family history of SCA12, unexplained ataxia, or those seeking presymptomatic testing after genetic counseling should consider this analysis.
يكشف هذا الفحص عن الطفرات المسببة للمرض في جين PPP2R2B المسبب للرنح النخاعي المخيخي النوع 12، وهو اضطراب وراثي سائد يظهر عادةً في البالغين.
2. How is the sample collected, and is home service available in UAE?
Sample collection can be performed via a simple blood draw (whole blood in EDTA tube), extracted DNA, or a single drop of blood on a DNA FTA Card. We offer fully licensed VIP mobile phlebotomy and hospital-grade home collection with cold-chain transport across all emirates, ensuring sample integrity from your doorstep to our ISO-certified lab.
يتم جمع العينة عن طريق سحب دم وريدي بسيط أو قطرة دم على بطاقة FTA، مع توفر خدمة السحب المنزلي المعتمدة والمجهزة بسلسلة تبريد في جميع الإمارات.
3. How reliable are the results and what support is provided afterward?
Our laboratory delivers analytical sensitivity and specificity exceeding 99.9% using dual-platform NGS and confirmatory sequencing, with results interpreted by board-certified clinical geneticists. Every report includes a complimentary telephonic post- consultation to explain findings, discuss implications for family members, and coordinate further neurological follow-up.
دقة تفوق 99.9% مع استشارة هاتفية مجانية بعد النتيجة لشرح التقرير والتوجيه السريري من قبل أخصائيي الوراثة المعتمدين.
UAE Healthcare Compliance
This service operates under Federal Decree-Law No. 41 of 2024 (Article 87) for genetic testing, UAE Personal Data Protection Law (PDPL) for data privacy, and CDS Law 2026 for minors' genetic testing. Facility License: 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). All genetic data is encrypted, stored within UAE sovereign boundaries, and handled with strict E-E-A-T and YMYL standards.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians